CVS Group (CVSG) interim results 2022 - March 2022

CVS Group CEO, Richard Fairman, CFO, Robin Alfonso and COO, Ben Jacklin present the interim results for the period ended 31 December 2021. Another strong set of results, with demand for their services continuing to increase. The positive trading momentum in H1 2022 has continued into the first two months of the second half and they are well placed to continue to invest and acquire to deliver further future growth. Richard Fairman, CEO00:17 – Introduction & Agenda01:05 – Growth strategy02:44 – Half Year highlights04:34 – Business model05:34 – Market dynamics06:24 – Opportunity for further acquisitions09:02 – ESG Robin Alfonso, CFO09:26 – Financial summary11:40 – Revenue growth13:05 – EBITDA growth13:47 – Highly cash generative14:39 – Deploying capital15:28 – Investing in practices16:09 – Greenfield opportunity Ben Jacklin, COO16:47 – Strategic update Richard Fairman, CEO24:39 – Current trading and outlook CVS Group plc (CVS) is a veterinary services provider. The Company operates in the four business segments, namely Veterinary Practices, Laboratories, Crematoria and Online Retail Business. It offers an integrated model with approximately 500 veterinary practices across its three territories, including eight specialist referral hospitals and 34 out-of-hours sites. Veterinary Practices provide specialist treatment for companion, equine and farm animals. The Company laboratories provide diagnostic services to CVS veterinary practices and third parties. It offers a range of tests with the ability to tailor specific profiles to its customers' needs. Its crematoria provide pet cremation and clinical waste services to CVS practices and third-party practices, and cremations to animal owners. CVS online retail business, Animed Direct, sells prescription and nonprescription medicines, pet foods and a range of pet care products.